Clinical and translational neuro-oncology
glioma, brain tumors, cognitive dysfunction
Research aim
We aim to improve treatments and clinical outcomes of patients with gliomas and other brain tumors, by combining expertise from oncobiology, neuropsychology, imaging, surgical & clinical neurology, and palliative care.
About us
Patients with gliomas and other primary brain tumors suffer from a cancer as well as a brain disease. Unfortunately, many brain tumors – to date – cannot be cured, but available treatments can still prolong life and optimize quality of life for many patients.
To offer new solutions and better outcomes for patients, expertise from clinical and experimental neuroscience needs to be combined with oncological science and care.
The expanding knowledge on glioma biology is used globally to develop new tumor treatments. Our team has a specific focus: understanding the interaction between the tumor biology, brain physiology and clinical outcomes. These clinical outcomes include the radiological tumor response; symptoms such as cognitive deficits and epilepsy; quality of life; and prolonging life (patient survival). The principal investigators and their team members combine expertise in oncobiology, neuroscience, neuropsychology, neuroimaging, epidemiology, quality of life, and palliative care.
Finally, to truly add value for patients’ lives, the input of patients and their loved ones is essential. We are developing new ways to include patients in neuro-oncological research and care, and to extend treatments to the patients’ practical and existential needs.